CLBFX
Price
$36.75
Change
+$0.18 (+0.49%)
Updated
Jul 3 closing price
Net Assets
251.2B
FPURX
Price
$25.72
Change
+$0.14 (+0.55%)
Updated
Jul 3 closing price
Net Assets
31.45B
Interact to see
Advertisement

CLBFX vs FPURX

Header iconCLBFX vs FPURX Comparison
Open Charts CLBFX vs FPURXBanner chart's image
American Funds American Balanced 529F
Price$36.75
Change+$0.18 (+0.49%)
VolumeN/A
Net Assets251.2B
Fidelity Puritan
Price$25.72
Change+$0.14 (+0.55%)
VolumeN/A
Net Assets31.45B
CLBFX vs FPURX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CLBFX vs. FPURX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBFX is a Buy and FPURX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBFX has more cash in the bank: 251B vs. FPURX (31.4B). CLBFX pays higher dividends than FPURX: CLBFX (1.99) vs FPURX (1.58). CLBFX was incepted earlier than FPURX: CLBFX (23 years) vs FPURX (78 years). CLBFX (0.67) is less costly to investors than FPURX (0.48). FPURX is a more actively managed with annual turnover of: 55.00 vs. CLBFX (44.00). FPURX has a lower initial minimum investment than CLBFX: FPURX (0) vs CLBFX (250). CLBFX annual gain was more profitable for investors over the last year : 8.02 vs. FPURX (-1.22). CLBFX return over 5 years is better than : 44.49 vs. FPURX (15.72).
CLBFXFPURXCLBFX / FPURX
Total Expense Ratio0.670.48140%
Annual Report Gross Expense Ratio0.670.48140%
Fund Existence23 years78 years-
Gain YTD8.1693.390241%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets251B31.4B799%
Annual Yield % from dividends1.991.58126%
Returns for 1 year8.02-1.22-658%
Returns for 3 years36.8019.06193%
Returns for 5 years44.4915.72283%
Returns for 10 years81.1430.63265%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IKT1.890.04
+2.16%
Inhibikase Therapeutics
VKTX28.190.47
+1.70%
Viking Therapeutics
ERIE346.943.85
+1.12%
Erie Indemnity Company
NVRI8.810.04
+0.46%
Enviri Corp
MTVA0.65-0.01
-2.10%
MetaVia Inc